7377-03-9CCCCCCCC(=O)NORGUVUPQQFXCJFC-UHFFFAOYSA-Nused as ruminal urease inhibitor; structure; RN given refers to unlabeled parent cpd
7377-03-9DTXSID8074609安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 96% (143 of 149) of all reports.
Not Classified
Aggregated GHS information provided per 149 reports by companies from 4 notifications to the ECHA C&L Inventory.
Chemical: Octanamide, N-hydroxy-
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
REACH registered substance: N-hydroxyoctanamide (EC: 230-936-7)
Caprylhydroxamic acid: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
説明Octanohydroxamic acid (OHA), the more common hydroxamate collector, has both an acid group (single bondNHOH) and basic group (single bond CO). The hydrogen in the acid group can be replaced by a metal ion and a dative bond from the basic group to form a chelate. Improved monazite flotation performance was reported when using OHA compared to the results obtained with sodium oleate. Flotation separation of monazite and calcite using OHA has been described in previous publications. OHA was the most potent urease inhibitor among saturated hydroxamic acid (HAs) with a calculated IC50 of 0.25±0.1mM compared to 8.67±1.3 and 0.50±0.2mM for Acetohydroxamic acid and heptanohydroxamic acid, respectively. Further increase in the chain length from 8 to 12 carbons negatively affected the potency of HAs[1].
使用Octanohydroxamic Acid is used in preparation of Caprylohydroxamic Acid.
現在のフィルター条件では反応記録がありません。
読み込み中…
定義本品は、次の化学式で表される有機化合物である。